Ability of vitamin D to reduce inflammation in adults without acute illness

Nutrition Reviews

Volumn 72, Issue 2, 2014, Pages 95-98

  Zanetti, Mayra ^a   Harris, Susan S ^b   Dawson Hughes, Bess ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b TUFTS UNIVERSITY   (United States)

Author keywords

25 hydroxyvitamin D; C reactive protein; Inflammation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ACUTE DISEASE; ARTICLE; CLINICAL TRIAL (TOPIC); CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; HUMAN; INFLAMMATION; INJURY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

25-HYDROXYVITAMIN D; C-REACTIVE PROTEIN; INFLAMMATION; VITAMIN D;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; HUMANS; INFLAMMATION; VITAMIN D;

EID: 84893564059     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12095     Document Type: Article

References (20)

1. Boucher BJ. The problems of vitamin D insufficiency in older people. Aging Dis. 2012;3:313-329.
2. Pludowski P, Holick MF, Pilz S, etal. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-A review of recent evidence. Autoimmun Rev. 2013;12:976-989.
3. Yang L, Ma J, Zhang X, etal. Protective role of the vitamin D receptor. Cell Immunol. 2012;279:160-166.
4. Dudani SJ, Kalhan S, Sharma SP. Vitamin D and multiple sclerosis: potential pathophysiological role and clinical implications. Int J Appl Basic Med Res. 2011;1:71-74.
5. Ansemant T, Mahy S, Piroth C, etal. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infect Dis. 2013;13:1-7.
6. Zhang Y, Leung DY, Richers BN, etal. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188:2127-2135.
7. Amer M, Qayyum R. Relation between serum 25-hydroxyvitamin D and C-reactive protein in asymptomatic adults (from the continuous National Health and Nutrition Examination Survey 2001 to 2006). Am J Cardiol. 2012;109:226-230.
8. Ngo DT, Sverdlov AL, McNeil JJ, etal. Does vitamin D modulate asymmetric dimethylarginine and C-reactive protein concentrations? Am J Med. 2010;123:335-341.
9. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: rationale for screening and primary prevention. Am J Cardiol. 2003;92:17K-22K.
10. Bellia A, Garcovich C, D'Adamo M, etal. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med. 2013;8:33-40.
11. Kim M, Na W, Sohn C. Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans. J Clin Biochem Nutr. 2013;52:167-171.
12. Garcia-Bailo B, Jamnik J, Da Costa LA, etal. Plasma 25-hydroxyvitamin D, hormonal contraceptive use, and the plasma proteome in Caucasian, East Asian, and South Asian young adults. J Proteome Res. 2013;12:1797-1807.
13. Garcia-Bailo B, Da Costa LA, Arora P, etal. Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009. Prev Chronic Dis. 2013;10:E91.
14. Da Costa LA, Arora P, Garcia-Bailo B, etal. The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults. Diabetes Metab Syndr Obes. 2012;5:347-355.
15. Brinkley TE, Hsu FC, Beavers KM, etal. Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach. J Gerontol A Biol Sci Med Sci. 2012;67:1099-1106.
16. Wildman RP, Kaplan R, Manson JE, etal. Body size phenotypes and inflammation in the Women's Health Initiative Observational Study. Obesity (Silver Spring). 2011;19:1482-1491.
17. Barnes MS, Horigan G, Cashman KD, etal. Maintenance of wintertime vitamin D status with cholecalciferol supplementation is not associated with alterations in serum cytokine concentrations among apparently healthy younger or older adults. J Nutr. 2011;141:476-481.
18. Jorde R, Sneve M, Torjesen PA, etal. No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects. Cytokine. 2010;50:175-180.
19. Beilfuss J, Berg V, Sneve M, etal. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine. 2012;60:870-874.
20. Yetley EA. Assessing the vitamin D status of the US population. Am J Clin Nutr. 2008;88(Suppl):558S-564S.